Selective Kv1.5 Blockers: Development of (R)-1-(Methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a Potential Treatment for Atrial Arrhythmia Article

Industry Collaboration

cited authors

  • Blass, Benjamin E.; Fensome, Andrew; Trybulski, Eugene; Magolda, Ronald; Gardell, Stephen J.; Liu, Kun; Samuel, Manoj; Feingold, Irene; Huselton, Christine; Jackson, Chris M.; Djandjighian, Laurent; Ho, Douglas; Hennan, James; Janusz, John M.

authors

Publication Date

  • November 12, 2009

webpage

published in

category

start page

  • 6531

end page

  • 6534

volume

  • 52

issue

  • 21